Guilford, Connecticut
United States
30
2020-10-29
The entities that hold a legal rights for patent applications filed by inventor Mull Eric:
Eric Mull from Guilford, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Indazole derivatives as alpha v integrin antagonists
#2 | 2020-06-04Immunomodulators acting as antagonists of PD-1
#3 | 2019-08-22Indazole derivatives as αv integrin antagonists
#4 | 2018-03-01Compounds useful as immunomodulators
#5 | 2017-12-28MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80(B7-1)/PD-L1 PROTEIN/PROTEIN INTERACTIONS
#6 | 2017-10-05Immunomodulators
#7 | 2017-10-05Immunomodulators
#8 | 2017-09-14Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
#9 | 2017-09-07Immunomodulators
#10 | 2017-04-20Compounds useful as immunomodulators
#11 | 2016-11-24Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
#12 | 2016-09-22Immunomodulators
#13 | 2016-08-04Immunomodulators
#14 | 2016-06-23Immunomodulators
#15 | 2016-06-23Immunomodulators
#16 | 2016-06-09Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
#17 | 2016-05-19Immunomodulators
#18 | 2016-04-14Immunomodulators
#19 | 2015-12-24Macrocyclic compounds as HCV entry inhibitors
#20 | 2015-10-08Hepatitis C virus inhibitors
#21 | 2015-10-08Hepatitis C virus inhibitors
#22 | 2015-05-07Hepatitis C virus inhibitors
#23 | 2014-10-02Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
#24 | 2013-05-09Hepatitis C virus inhibitors
#25 | 2012-08-23Compounds for the treatment of hepatitis C
#26 | 2012-04-19Compounds for the treatment of hepatitis C
#27 | 2012-04-19Compounds for the treatment of hepatitis C
#28 | 2011-04-14Compounds for the treatment of hepatitis C
#29 | 2009-10-15Pyrimidine Derivatives
#30 | 2009-10-01Indane amides
234073 ⎘